We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3391:TSETSURUHA Holdings, Inc. Analysis

Data as of 2026-06-18 - not real-time

¥2,027.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Tsuruha Holdings trades around ¥2,027, notably below its DCF‑derived fair value of roughly ¥2,093, implying an upside of about 28% and positioning the stock as potentially undervalued. Fundamentally, the company posts a modest PE of 14 versus an industry average of 24, a forward PE near 3, and a price‑to‑book ratio close to parity, suggesting cheapness relative to peers. However, revenue growth is flat and the balance sheet shows a high debt‑to‑equity ratio, tempering enthusiasm. Technically, the price sits just above the 20‑day SMA but remains under the 50‑day and 200‑day averages, with a bearish trend, decreasing volume, and a neutral RSI around 48, while the MACD histogram is positive, hinting at limited short‑term momentum.
Given the current market sentiment of “Extreme Greed” and a low beta indicating limited correlation with broader market moves, the stock may benefit from defensive investors seeking value. Yet, the elevated 30‑day volatility (over 36%) and a historical max drawdown near 36% underscore considerable risk, especially if the bearish trend persists.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish price trend relative to longer‑term moving averages
  • Support level near ¥1,889 limiting downside potential
  • MACD histogram positive but overall market momentum weak

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant upside to DCF fair value and low relative PE
  • Strong cash generation versus debt despite high leverage
  • Forward earnings expectations driving a low forward PE

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Defensive healthcare retail business with stable cash flows
  • Low beta and defensive sector characteristics
  • Reinvestment focus with no dividend but solid free cash flow

Key Metrics & Analysis

Financial Health

Profit Margin2.94%
P/E Ratio14.1
ROE7.55%
ROA3.53%
Debt/Equity23.28
P/B Ratio1.0
Op. Cash Flow¥84.6B
Free Cash Flow¥71.9B
Industry P/E24.1

Technical Analysis

TrendBearish
RSI47.7
Support¥1,889.00
Resistance¥2,135.00
MA 20¥2,006.45
MA 50¥2,074.61
MA 200¥2,447.91
MACDBullish
VolumeDecreasing
Fear & Greed Index90.79

Valuation

Fair Value¥2,093.44
Target Price¥2,596.67
Upside/Downside28.10%
GradeUndervalued
TypeValue

Risk Assessment

Beta-0.57
Volatility36.21%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.